1 INTRODUCTION OF GLOBAL MEDICAL AESTHETICS DEVICES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL MEDICAL AESTHETICS DEVICES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 DEVICES
5.2.1 AESTHETIC LASERS
5.2.1.1 ABLATIVE LASERS
5.2.1.2 NON-ABLATIVE LASERS
5.2.2 SKIN TIGHTENING & BODY CONTOURING DEVICES
5.2.2.1 LIPOSUCTION DEVICES
5.2.2.2 SKIN TIGHTENING DEVICES
5.2.2.3 CELLULITE REDUCTION DEVICES
5.3 AESTHETIC IMPLANTS
5.3.1 DENTAL IMPLANTS
5.3.1.1 ROOT FORM DENTAL IMPLANTS
5.3.1.2 PLATE FORM DENTAL IMPLANTS
5.3.2 BREAST IMPLANTS
5.3.2.1 SALINE FILLED
5.3.2.2 SILICONE GEL-FILLED
5.4 FACIAL IMPLANTS
5.5 OTHER IMPLANTS
6 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 SURGICAL
6.2.1 FACE & HEAD
6.2.1.1 BROW LIFT
6.2.1.2 EAR SURGERY
6.2.1.3 EYELID SURGERY
6.2.1.4 FACELIFT
6.2.1.5 FACIAL BONE CONTOURING
6.2.1.6 FACIAL FAT GRAFTING
6.2.1.7 NECK LIFT
6.2.1.8 HAIR TRANSPLANTATION
6.2.1.9 RHINOPLASTY
6.2.2 BREAST
6.2.2.1 BREAST AUGMENTATION
6.2.2.2 BREAST LIFT
6.2.3 BODY & EXTREMITIES
6.2.3.1 ABDOMINOPLASTY
6.2.3.2 BUTTOCK AUGMENTATION
6.2.3.3 BUTTOCK LIFT
6.2.3.4 LIPOSUCTION
6.2.3.5 LOWER BODY LIFT
6.2.3.6 PENILE ENLARGEMENT
6.2.3.7 THIGH LIFT
6.2.3.8 UPPER ARM LIFT
6.2.3.9 UPPER BODY LIFT
6.2.3.10 LABIAPLASTY
6.2.3.11 VAGINAL REJUVENATION
6.3 NON-SURGICAL
7 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 MEDICAL SPAS & BEAUTY CENTERS

8 GLOBAL MEDICAL AESTHETICS DEVICES MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE

8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL MEDICAL AESTHETICS DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 ABBVIE INC. (ALLERGAN PLC)
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 ALMA LASERS LTD (SISRAM MED)
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BAUSCH HEALTH COMPANIES INC. (SOLTA MEDICAL INC.)
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 CUTERA INC.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 EL.EN. (ASCLEPION LASER TECHNOLOGIES)
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 CYNOSURE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 LUMENIS INC.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8. SCITON INC.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 SYNERON MEDICAL LTD
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 GALDERMA
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.11 JOHNSON & JOHNSON
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS

10.12 MERZ PHARMA GMBH & CO. KGAA
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS